4.6 Article

Long non-coding RNA LINC01748 exerts carcinogenic effects in non-small cell lung cancer cell lines by regulating the microRNA-520a-5p/HMGA1 axis

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Long non-coding RNA CCAT1 promotes non-small cell lung cancer progression by regulating the miR-216a-5p/RAP2B axis

Lingling Pang et al.

Summary: This study revealed that CCAT1 deletion could inhibit cell progression in NSCLC via the miR-216a-5p/RAP2B axis. Additionally, the interaction between miR-216a-5p and CCAT1 or RAP2B was identified, providing a novel pathway for understanding NSCLC cell progression and potential targets for NSCLC treatment.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

Article Oncology

LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival

Yanhui Wan et al.

Summary: In this study, we found that WT1-AS was downregulated in NSCLC and correlated with poor survival. On the other hand, UCA1 was upregulated in cancer tissues and inversely correlated with WT1-AS. Overexpression of WT1-AS inhibited the expression of UCA1, leading to decreased proliferation, EMT, migration, and invasion of NSCLC cells.

BMC CANCER (2021)

Article Oncology

LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis

Kai Guo et al.

Summary: The study revealed that lncRNA MEG8 plays a critical role in the development of NSCLC by modulating the miR-15a/b-5p/PSAT1 axis, indicating that lncRNA MEG8, miR-15a-5p, miR-15b-5p, and PSAT1 may serve as potential targets for NSCLC therapy.

CANCER CELL INTERNATIONAL (2021)

Article Biochemistry & Molecular Biology

LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p

Lei Zhang et al.

Summary: This study revealed the prognostic significance of lncRNA CCDC144NL-AS1 in NSCLC patients, discussed its effects on proliferation, migration, and invasion of NSCLC cells, and potentially targeted miR-490-3p for regulation.

MOLECULAR BIOTECHNOLOGY (2021)

Article Cell Biology

LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer

Jian Xu et al.

Summary: The study reveals that lncRNA CERS6-AS1 is highly expressed in pancreatic cancer and correlates with poor prognosis. Downregulation of CERS6-AS1 significantly inhibits proliferation and migration of pancreatic cancer cells. Furthermore, CERS6-AS1 regulates the proliferation and metastasis of PC cells through the miR-217/YWHAG/RAF1 signaling axis.

CELL DEATH & DISEASE (2021)

Article Oncology

LncRNA SNHG17 Contributes to the Progression of Cervical Cancer by Targeting microRNA-375-3p

Shuping Cao et al.

Summary: This study aimed to clarify the clinical significance and biological function of lncRNA SNHG17 and miRNA-375-3p in cervical cancer. Results showed that SNHG17 and miR-375-3p could potentially be diagnostic markers for CC, with SNHG17 promoting the progression of CC partly via targeting miR-375-3p, suggesting a novel therapeutic target for CC.

CANCER MANAGEMENT AND RESEARCH (2021)

Article Cell Biology

LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer

Dexin Jia et al.

Summary: The study identified LINC02678 as an upregulated lncRNA in NSCLC, associated with poor prognosis in lung cancer patients. It was found to promote NSCLC progression by binding with EZH2 and enhancing cell proliferation and metastasis, suggesting its potential as a biomarker for cancer diagnosis and treatment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Urology & Nephrology

Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop

Tongbin Gao et al.

Summary: This study found that LINC00707 was upregulated in bladder cancer samples and cells, and its higher expression was associated with advanced stage, grade, and shorter survival time. Silencing LINC00707 suppressed cell proliferation, colony formation, and metastasis. Mechanistic studies revealed that LINC00707 targeted miR-145/CDCA3 and inactivated the Wnt/beta-catenin signaling pathway.

UROLOGIA INTERNATIONALIS (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Respiratory System

Lung Cancer Pathology Current Concepts

William D. Travis

CLINICS IN CHEST MEDICINE (2020)

Review Cell Biology

Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer

Cheng Fang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Review Genetics & Heredity

Structure, Regulation, and Function of Linear and Circular Long Non-Coding RNAs

Tao Qin et al.

FRONTIERS IN GENETICS (2020)

Article Oncology

LncRNA NEAT1/miR-204/NUAK1 Axis is a Potential Therapeutic Target for Non-Small Cell Lung Cancer

Ming-Ming Zhao et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Article Cell Biology

LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1

Fei Yan et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Medicine, General & Internal

New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives

Ramon Andrade de Mello et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Medicine, Research & Experimental

New insights into long non-coding RNAs in non-small cell lung cancer

Ruifang Ye et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Respiratory System

Update 2020: Management of Non-Small Cell Lung Cancer

Mariam Alexander et al.

Article Biochemistry & Molecular Biology

ELK1-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/HMGA1 axis

Bo Huang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Review Medicine, General & Internal

Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Narjust Duma et al.

MAYO CLINIC PROCEEDINGS (2019)

Review Biochemistry & Molecular Biology

Emerging roles of lncRNAs in the post-transcriptional regulation in cancer

Rong-Zhang He et al.

GENES & DISEASES (2019)

Review Cell Biology

Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer

Wei Peng et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Review Biotechnology & Applied Microbiology

Potential clinical application of lncRNAs in non-small cell lung cancer

Tong Lu et al.

ONCOTARGETS AND THERAPY (2018)

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

Review Oncology

The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer

Hongjing Zang et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)

Review Oncology

MicroRNAs in lung cancer

Diana Castro et al.

ONCOTARGET (2017)

Review Oncology

Long Noncoding RNA and Cancer: A New Paradigm

Arunoday Bhan et al.

CANCER RESEARCH (2017)

Article Genetics & Heredity

ceRNA in cancer: possible functions and clinical implications

Xiaolong Qi et al.

JOURNAL OF MEDICAL GENETICS (2015)

Review Cell Biology

Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets

Jing Chen et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)

Review Biochemistry & Molecular Biology

Long Noncoding RNAs: Cellular Address Codes in Development and Disease

Pedro J. Batista et al.

Article Biochemistry & Molecular Biology

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

Leonardo Salmena et al.

Article Multidisciplinary Sciences

Mammalian microRNAs predominantly act to decrease target mRNA levels

Huili Guo et al.

NATURE (2010)

Review Oncology

MicroRNA signatures in human cancers

George A. Calin et al.

NATURE REVIEWS CANCER (2006)

Article Oncology

Increased expression of high mobility group A proteins in lung cancer

V. K. Sarhadi et al.

JOURNAL OF PATHOLOGY (2006)